Should I Buy CMBM? CMBM 2026 Analysis

Should You Buy Cambium Networks Corp (CMBM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.490

1 Day change

-6.29%

52 Week Range

6.800

Analysis Updated At

2026/01/28

Not a good buy right now for a beginner, long-term investor who wants to enter immediately. Despite a mildly bullish moving-average setup, the stock has extremely high volatility, weak profitability trends, no near-term catalysts, and pattern-based odds point to a negative next-month bias. I would wait rather than buy at $1.655.

Technical Analysis

**Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently. **Trend/levels**: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting an improving trend structure. However, MACD histogram is positive but *contracting* (momentum is fading), and RSI(6)=48.48 is neutral (no strong demand pressure). Price is near the pivot (1.641). Near-term support is S1=1.507 (then S2=1.425); resistance is R1=1.775 (then R2=1.857). With momentum fading, risk/reward is not attractive for an impatient entry. **Stat/pattern read**: Similar-pattern projection shows -7.94% expected bias over the next month, reinforcing a “wait/hold” stance.

Options Data

Neutral

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open-interest put/call ratio at 1.04 is slightly put-heavy (cautious/neutral-to-bearish positioning). However, today’s volume put/call ratio at 0.63 is call-leaning (more bullish activity *today*). Activity is unusually elevated (today’s volume ~25x the 30-day average; open interest also unusually high vs average), which signals heightened speculation. IV is low vs its own history (IV percentile ~13), but absolute IV is still extremely high (30D IV ~190%), meaning the name remains very risk-heavy for beginners.

Technical Summary

Sell

Buy

Positive Catalysts

Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200). Gross margin improved sharply in the latest reported quarter (2024/Q3). Options volume skew today leans bullish (put/call volume 0.63).

Neutral/Negative Catalysts

No news/catalysts in the last week to drive a sustained re-rating. Profitability deteriorated (larger net loss and EPS decline YoY in 2024/Q3). Extremely high realized/implied volatility makes long-term entry timing less forgiving. Pattern-based outlook suggests downside over the next month (-7.94%).

Financial Performance

Latest provided quarter: 2024/Q3. Revenue was $43.726M (+1.58% YoY), but net income fell to -$9.676M (worse by -63.07% YoY) and EPS to -0.34 (-64.21% YoY). Gross margin improved to 36.05 (+64.84% YoY). Overall: slight top-line growth and better margin, but losses widened—still not a clean long-term compounding profile at the moment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price-target change data was provided, so a recent Wall Street consensus trend cannot be confirmed from this dataset. With missing coverage signals and weak earnings trend, the ‘pro’ case is mainly technical stabilization and margin improvement; the ‘con’ case is ongoing losses and very high volatility.

Analyst Rating

Wall Street analysts forecast CMBM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CMBM is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy